739.1500 -5.45 (-0.73%)
NSE Sep 22, 2025 15:31 PM
Volume: 239.5K
 

ICICI Securities Limited
Krishna Institute of Medical Sciences’ (KIMS) Q3FY25 revenue was in-line while EBITDA and PAT were dragged by seasonality and its new Nashik hospitals. KIMS’ hospitals in Telangana/Andhra Pradesh grew a robust 26.1%/27.8% YoY. In Q3FY25, it commenced operations at its 325-bed hospital in Nashik (EBITDA loss of INR 50mn in Q3FY25), which is likely to break even by Q3FY26.
Krishna Institute of Medical Sciences Ltd. is trading above its 200 day SMA of 653.2
More from Krishna Institute of Medical Sciences Ltd.
Recommended